Search by Drug Name or NDC

    NDC 00006-3822-10 CANCIDAS 5 mg/mL Details

    CANCIDAS 5 mg/mL

    CANCIDAS is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is CASPOFUNGIN ACETATE.

    Product Information

    NDC 00006-3822
    Product ID 0006-3822_39327580-560c-4bab-a6a2-e7f042420e16
    Associated GPIs 11500025102120
    GCN Sequence Number 047688
    GCN Sequence Number Description caspofungin acetate VIAL 50 MG INTRAVEN
    HIC3 W3A
    HIC3 Description ANTIFUNGAL ANTIBIOTICS
    GCN 12612
    HICL Sequence Number 021909
    HICL Sequence Number Description CASPOFUNGIN ACETATE
    Brand/Generic Brand
    Proprietary Name CANCIDAS
    Proprietary Name Suffix n/a
    Non-Proprietary Name CASPOFUNGIN ACETATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name CASPOFUNGIN ACETATE
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Echinocandin Antifungal [EPC], Lipopeptides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021227
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-3822-10 (00006382210)

    NDC Package Code 0006-3822-10
    Billing NDC 00006382210
    Package 1 VIAL, SINGLE-USE in 1 CARTON (0006-3822-10) / 10.8 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2001-01-26
    NDC Exclude Flag N
    Pricing Information N/A